Tim Caulfield, LLM
Office: 461, Law Centre
Mail: University of Alberta, Edmonton, AB T6G 2H5
Canada Research Chair in Health Law and Policy
Professor, Faculty of Law and School of Public Health
Director, Faculty of Law's Health Law and Science Policy Group (HeaLS)
Health law, biotechnology policy, bioethics
Timothy Caulfield is a Canada Research Chair in Health Law and Policy and a Professor in the Faculty of Law and the School of Public Health at the University of Alberta. He was the Research Director of the Health Law Institute at the University of Alberta from 1993 to 2011 and is now leading the Faculty of Law’s Health Law and Science Policy Group (HeaLS). Over the past several years he has been involved in a variety of interdisciplinary research endeavours that have allowed him to publish over 250 articles and book chapters. He is a Health Senior Scholar with the Alberta Heritage Foundation for Medical Research and the Principal Investigator for a number of large interdisciplinary projects that explore the ethical, legal and health policy issues associated with a range of topics, including stem cell research, genetics, patient safety, the prevention of chronic disease, obesity policy, the commercialization of research, complementary and alternative medicine and access to health care. Professor Caulfield is and has been involved with a number of national and international policy and research ethics committees, including Canadian Biotechnology Advisory Committee, Genome Canada’s Science Advisory Committee, and the Federal Panel on Research Ethics. He is a Fellow of the Royal Society of Canada and the Canadian Academy of Health Sciences. He writes frequently for the popular press and is the author of The Cure for Everything: Untangling the Twisted Messages about Health, Fitness and Happiness.
Books, Book Chapters, Edited Collections & Reports
Tracey Bailey, Timothy Caulfield, Nola Ries, eds. Public Health Law and Policy. Chapter contribution: “Genetics and Public Health: Legal, Ethical and Policy Challenges.” Toronto: Butterworths, 477-495 pp., 2005.
Timothy Caulfield, "Stem Cells, Clones, Consensus and the Law" in Lori Knowles and Gregory E. Kaebnick, eds. Shaping Our Future: Law, Policy, and Ethics in an Era of Reproductive Genetics. Johns Hopkins University Press: Baltimore, forthcoming.
Timothy Caulfield. “Human Cloning and Stem Cell Policies: Balancing Public Opinion and Moral Perspectives” in A. Eisen and G. Laderman, eds. Science, Religion, and Society: History, Culture, and Controversy. ME Sharpe: New York, in press.
Timothy Caulfield, Barb von Tigerstrom. “Globalization and Biotechnology Policy: The Challenges Created by Gene Patents and Cloning Technologies” in Belinda Bennett and George F. Tomossy, eds. Globalization and Health: Challenges for Health Law and Bioethics. Springer: International Library of Ethics, Law and the New Medicine, 129-149 pp., 2005.
Jocelyn Downie, Timothy Caulfield, Colleen Flood, eds. Canadian Health Law and Policy, Second Edition. Toronto: Butterworths, 601 pp., 2002.
Timothy Caulfield, Tania Bubela. “Why a Criminal Ban?: Analyzing the Arguments Against Somatic Cell Nuclear Transfer in the Canadian Parliamentary Debate.” American Journal of Bioethics (accepted for publication).
Timothy Caulfield, Edna Einsiedel, Jon Merz, Dianne Nicol. “Trust, Patents, and Public Perceptions: The Governance of Controversial Biotechnology Research” Nature Biotechnology (in press 2006).
T. Caulfield, B. Cook-Deegan, S. Kieff, J. Walsh, “Evidence and Anecdotes: An Analysis of Human Gene Patenting Controversies.” 24 Nature Biotechnology 1091-1094, 2006.
Timothy Caulfield, “Introduction: Genetic Diversity and Science Communication.” 70 Clinical Genetics 424-426, 2006.
Timothy Caulfield, Barbara von Tigerstrom, “Gene Patents, Health Care Policy and Licensing Schemes.” 24 Trends in Biotechnology 251-254, 2006.
Nola Ries, Timothy Caulfield, “First Pharmacogenomics, Next Nutrigenomics: Genohype or Genohealthy?” 46 Jurimetrics 281-308, 2006.
Timothy Caulfield, “Stem Cell Patents and Social Controversy: A Speculative View From Canada.” 7 Medical Law International 219-232, 2006.
Yann Joly, Richard Gold, Timothy Caulfield, "Genetic Research Tools, the Research Exception and Open Science." 3 GeneEdit http://www.humgen.umontreal.ca/int/GE/en/2005-2.pdf, 2005
Timothy Caulfield, Roger Brownsword, “Human Dignity: What Does It Mean in the Biotechnology Era?” 7 Nature Reviews Genetics 72-76, 2005.
Timothy Caulfield, "Popular Media, Biotechnology and the 'Cycle of Hype'." 5 Journal of Health Law and Policy 213-233, 2005.
Timothy Caulfield, Audrey Chapman, “Human Dignity as a Criterion for Science Policy.” 2 PLoS Medicine 101-103, 2005.